Cargando…

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study

Analytical methods for the quantification of the new 8-aminoquinoline antimalarial tafenoquine (TQ) in human blood, plasma and urine, and the 5,6-orthoquinone tafenoquine metabolite (5,6-OQTQ) in human plasma and urine have been validated. The procedure involved acetonitrile extraction of samples fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Birrell, Geoffrey W., Van Breda, Karin, Barber, Bridget, Webster, Rebecca, McCarthy, James S., Shanks, G. Dennis, Edstein, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737280/
https://www.ncbi.nlm.nih.gov/pubmed/36500278
http://dx.doi.org/10.3390/molecules27238186
_version_ 1784847246662041600
author Birrell, Geoffrey W.
Van Breda, Karin
Barber, Bridget
Webster, Rebecca
McCarthy, James S.
Shanks, G. Dennis
Edstein, Michael D.
author_facet Birrell, Geoffrey W.
Van Breda, Karin
Barber, Bridget
Webster, Rebecca
McCarthy, James S.
Shanks, G. Dennis
Edstein, Michael D.
author_sort Birrell, Geoffrey W.
collection PubMed
description Analytical methods for the quantification of the new 8-aminoquinoline antimalarial tafenoquine (TQ) in human blood, plasma and urine, and the 5,6-orthoquinone tafenoquine metabolite (5,6-OQTQ) in human plasma and urine have been validated. The procedure involved acetonitrile extraction of samples followed by ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS). Chromatography was performed using a Waters Atlantis T3 column with a gradient of 0.1% formic acid and acetonitrile at a flow rate of 0.5 mL per minute for blood and plasma. Urine analysis was the same but with methanol containing 0.1% formic acid replacing acetonitrile mobile phase. The calibration range for TQ and 5,6-OQTQ in plasma was 1 to 1200 ng/mL, and in urine was 10 to 1000 ng/mL. Blood calibration range for TQ was 1 to 1200 ng/mL. Blood could not be validated for 5,6-OQTQ due to significant signal suppression. The inter-assay precision (coefficient of variation %) was 9.9% for TQ at 1 ng/mL in blood (n = 14) and 8.2% for TQ and 7.1% for 5,6-OQTQ at 1 ng/mL in plasma (n = 14). For urine, the inter-assay precision was 8.2% for TQ and 6.4% for 5,6-OQTQ at 10 ng/mL (n = 14). TQ and 5,6-OQTQ are stable in blood, plasma and urine for at least three months at both −80 °C and −20 °C. Once validated, the analytical methods were applied to samples collected from healthy volunteers who were experimentally infected with Plasmodium falciparum to evaluate the blood stage antimalarial activity of TQ and to determine the therapeutic dose estimates for TQ, the full details of which will be published elsewhere. In this study, the measurement of TQ and 5,6-OQTQ concentrations in samples from one of the four cohorts of participants is reported. Interestingly, TQ urine concentrations were proportional to parasite recrudescence times post dosing To our knowledge, this is the first description of a fully validated method for the measurement of TQ and 5,6-OQTQ quantification in urine.
format Online
Article
Text
id pubmed-9737280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97372802022-12-11 Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study Birrell, Geoffrey W. Van Breda, Karin Barber, Bridget Webster, Rebecca McCarthy, James S. Shanks, G. Dennis Edstein, Michael D. Molecules Article Analytical methods for the quantification of the new 8-aminoquinoline antimalarial tafenoquine (TQ) in human blood, plasma and urine, and the 5,6-orthoquinone tafenoquine metabolite (5,6-OQTQ) in human plasma and urine have been validated. The procedure involved acetonitrile extraction of samples followed by ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS). Chromatography was performed using a Waters Atlantis T3 column with a gradient of 0.1% formic acid and acetonitrile at a flow rate of 0.5 mL per minute for blood and plasma. Urine analysis was the same but with methanol containing 0.1% formic acid replacing acetonitrile mobile phase. The calibration range for TQ and 5,6-OQTQ in plasma was 1 to 1200 ng/mL, and in urine was 10 to 1000 ng/mL. Blood calibration range for TQ was 1 to 1200 ng/mL. Blood could not be validated for 5,6-OQTQ due to significant signal suppression. The inter-assay precision (coefficient of variation %) was 9.9% for TQ at 1 ng/mL in blood (n = 14) and 8.2% for TQ and 7.1% for 5,6-OQTQ at 1 ng/mL in plasma (n = 14). For urine, the inter-assay precision was 8.2% for TQ and 6.4% for 5,6-OQTQ at 10 ng/mL (n = 14). TQ and 5,6-OQTQ are stable in blood, plasma and urine for at least three months at both −80 °C and −20 °C. Once validated, the analytical methods were applied to samples collected from healthy volunteers who were experimentally infected with Plasmodium falciparum to evaluate the blood stage antimalarial activity of TQ and to determine the therapeutic dose estimates for TQ, the full details of which will be published elsewhere. In this study, the measurement of TQ and 5,6-OQTQ concentrations in samples from one of the four cohorts of participants is reported. Interestingly, TQ urine concentrations were proportional to parasite recrudescence times post dosing To our knowledge, this is the first description of a fully validated method for the measurement of TQ and 5,6-OQTQ quantification in urine. MDPI 2022-11-24 /pmc/articles/PMC9737280/ /pubmed/36500278 http://dx.doi.org/10.3390/molecules27238186 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Birrell, Geoffrey W.
Van Breda, Karin
Barber, Bridget
Webster, Rebecca
McCarthy, James S.
Shanks, G. Dennis
Edstein, Michael D.
Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title_full Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title_fullStr Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title_full_unstemmed Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title_short Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
title_sort quantification of tafenoquine and 5,6-orthoquinone tafenoquine by uhplc-ms/ms in blood, plasma, and urine, and application to a pharmacokinetic study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737280/
https://www.ncbi.nlm.nih.gov/pubmed/36500278
http://dx.doi.org/10.3390/molecules27238186
work_keys_str_mv AT birrellgeoffreyw quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT vanbredakarin quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT barberbridget quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT websterrebecca quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT mccarthyjamess quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT shanksgdennis quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy
AT edsteinmichaeld quantificationoftafenoquineand56orthoquinonetafenoquinebyuhplcmsmsinbloodplasmaandurineandapplicationtoapharmacokineticstudy